Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-782P is a pseudogene belonging to the U6 small nuclear RNA (snRNA) family, catalogued as a non-coding RNA in the human genome[3][4][6][8][9]. This gene does not encode a functional RNA product and is not transcribed into a protein. The canonical U6 snRNA genes are integral to pre-mRNA splicing within the spliceosome, but pseudogenes such as RNU6-782P are non-functional genomic sequences thought to arise from duplication or retrotransposition events, and typically do not participate in cellular or disease processes[6][8][9]. There is no evidence linking this pseudogene to any biological functions, disease mechanisms, or therapeutic roles, and it is not considered a therapeutic target[6][8][9]. The standard U6 small nuclear RNA (not the pseudogene) is an essential component of the spliceosome, but pseudogenes like RNU6-782P lack such activity[5]. There are no known drugs, disease associations, or biomarker roles for RNU6-782P. Listing as a pseudogene means it should not be considered a therapeutic, diagnostic, or research target in the traditional sense.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 782, pseudogene (RNU6-782P).